1. Home
  2. HQ vs DNA Comparison

HQ vs DNA Comparison

Compare HQ & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Quantum Holdings Ltd. Class A Ordinary Shares

HQ

Horizon Quantum Holdings Ltd. Class A Ordinary Shares

HOLD

Current Price

$16.08

Market Cap

879.7M

Sector

N/A

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

SELL

Current Price

$11.77

Market Cap

835.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HQ
DNA
Founded
2018
2008
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
879.7M
835.7M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
HQ
DNA
Price
$16.08
$11.77
Analyst Decision
Buy
Sell
Analyst Count
2
3
Target Price
★ $20.50
$7.00
AVG Volume (30 Days)
440.5K
★ 3.3M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 46.49
EPS
★ N/A
N/A
Revenue
N/A
★ $170,155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.37
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$8.29
$5.37
52 Week High
$45.00
$18.22

Technical Indicators

Market Signals
Indicator
HQ
DNA
Relative Strength Index (RSI) 51.95 56.18
Support Level $13.68 $6.75
Resistance Level $16.37 N/A
Average True Range (ATR) 1.22 1.72
MACD 0.18 0.03
Stochastic Oscillator 57.54 33.74

Price Performance

Historical Comparison
HQ
DNA

About HQ Horizon Quantum Holdings Ltd. Class A Ordinary Shares

Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: